CanSino Biologics

Business Area(s): 
Description: 

CanSino Biologics Inc. (CanSinoBIO, stock 6185.HK) is a biopharmaceutical company dedicated to exploring the prevention of diseases through research & development, advanced manufacturing and commercialization of vaccine products for human use worldwide. 

Rcently started human testing of their recombinant vaccine, which uses adenovirus type 5 as the vector to express the SARS-CoV-2 spike protein.

Career Page(s): 
Location(s): 
Tianjin
China
Causeway Bay
Hong Kong S.A.R., China